- Home
- KTCC vs AKTX Comparison
KTCC vs AKTX Comparison
Compare KTCC & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- AKTX
- Stock Information
- Founded
- KTCC 1969
- AKTX N/A
- Country
- KTCC United States
- AKTX United States
- Employees
- KTCC N/A
- AKTX N/A
- Industry
- KTCC Electrical Products
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- AKTX Health Care
- Exchange
- KTCC Nasdaq
- AKTX Nasdaq
- Market Cap
- KTCC 34.0M
- AKTX 29.5M
- IPO Year
- KTCC N/A
- AKTX N/A
- Fundamental
- Price
- KTCC $2.30
- AKTX $1.16
- Analyst Decision
- KTCC
- AKTX
- Analyst Count
- KTCC 0
- AKTX 0
- Target Price
- KTCC N/A
- AKTX N/A
- AVG Volume (30 Days)
- KTCC 27.6K
- AKTX 28.1K
- Earning Date
- KTCC 05-06-2025
- AKTX 05-15-2025
- Dividend Yield
- KTCC N/A
- AKTX N/A
- EPS Growth
- KTCC N/A
- AKTX N/A
- EPS
- KTCC N/A
- AKTX N/A
- Revenue
- KTCC $514,394,000.00
- AKTX N/A
- Revenue This Year
- KTCC N/A
- AKTX N/A
- Revenue Next Year
- KTCC N/A
- AKTX N/A
- P/E Ratio
- KTCC N/A
- AKTX N/A
- Revenue Growth
- KTCC N/A
- AKTX N/A
- 52 Week Low
- KTCC $2.25
- AKTX $0.85
- 52 Week High
- KTCC $6.14
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- KTCC 29.20
- AKTX 48.66
- Support Level
- KTCC $2.38
- AKTX $1.05
- Resistance Level
- KTCC $2.70
- AKTX $1.23
- Average True Range (ATR)
- KTCC 0.10
- AKTX 0.13
- MACD
- KTCC 0.01
- AKTX -0.02
- Stochastic Oscillator
- KTCC 8.33
- AKTX 14.69
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).